Chairs
Current Chair: Neha Patel
Chair-elect candidate: Dania Alhamad
BOD Liaison
Laurie Cohen
Charged with keeping the Society informed on topics about both new and existing drugs and devices. To review problems related to the therapeutics of Pediatric Endocrine disorders and report to the Board of Directors and the greater membership of PES.
New Meds and Tech: Mounjaro (tirzepatide) approved in Pediatrics
February 24, 2026
Mounjaro (tirzepatide) approved in Pediatrics Prepared on behalf of PES Drugs…
Drug alerts and recalls – Depo-Provera and Increased Risk of Meningioma: FDA-Label Update
February 24, 2026
Depo-Provera and Increased Risk of Meningioma: FDA-Label Update. Written by:…
News from the D&T: KHINDIVI™ (hydrocortisone) Oral Solution
July 28, 2025
KHINDIVI™ (hydrocortisone) Oral Solution In May 2025, the FDA approved…